почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Rozel 60 mg PFS
Rozel 60 mg PFS
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$226.65 $161.83
Rozel 60 mg PFS is an essential medication designed to combat osteoporosis, a condition characterized by reduced bone density that increases the risk of fractures, particularly in men and postmenopausal...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
Denosumab 60 mg
Active Pharmaceutical Ingredient
Rozel 60 mg PFS
226,65 $
161,83 $
Rozel 60 mg PFS is an essential medication designed to combat osteoporosis, a condition characterized by reduced bone density that increases the risk of fractures, particularly in men and postmenopausal women who are at heightened risk and have not found relief with alternative treatments. This powerful formulation is also effective in addressing bone loss in men undergoing prostate cancer therapy and women receiving treatment for breast cancer, as both can lead to significant bone deterioration. Furthermore, Rozel 60 mg plays a crucial role in minimizing the risk of fractures in patients battling bone cancer and multiple myeloma, a type of blood cancer. By acting on the underlying mechanisms of bone metabolism, Rozel helps reinforce bone strength and integrity. It's important to note that while Rozel is beneficial for these conditions, patients should discuss potential side effects and contraindications with their healthcare provider to ensure safe usage. This medication is a vital option for those who require additional support in maintaining bone health during challenging medical treatments. As always, following your doctor’s guidance is crucial for optimal outcomes.
Active Pharmaceutical Ingredient
Применение
• Rozel 60 mg pfs is indicated for the treatment of osteoporosis, a condition characterized by reduced bone density, which increases the risk of fractures. It is particularly beneficial for men and postmenopausal women who face a high risk of bone-related complications. This medication is often prescribed when patients have not seen adequate results from other osteoporosis treatments. By helping to strengthen bone structure, Rozel 60 mg pfs plays a crucial role in improving overall bone health.
• In patients suffering from osteolytic bone metastases associated with solid tumors, Rozel 60 mg pfs is utilized to address bone loss. This is especially relevant for men diagnosed with prostate cancer and women with breast cancer, as their treatments can lead to significant bone degradation. By mitigating the effects of these treatments, Rozel 60 mg pfs helps maintain bone integrity and reduce the risk of fractures. Thus, it serves as an important adjunct in the management of cancer-related bone health issues.
• Rozel 60 mg pfs can be an effective option for patients at high risk of fractures due to osteoporosis. The medication works by enhancing bone density and strength, which is vital for individuals with a history of bone fractures or those who have experienced significant bone loss. Many healthcare providers recommend Rozel 60 mg pfs as part of a comprehensive treatment plan tailored to the needs of these patients. Its role in fracture prevention is particularly important for maintaining quality of life in at-risk populations.
• For individuals undergoing treatment for cancers that affect bone health, Rozel 60 mg pfs is an essential part of their therapeutic regimen. By addressing the bone loss associated with certain cancer therapies, this medication helps to preserve bone mass and prevent complications. Patients receiving Rozel 60 mg pfs often report improvements in their overall bone condition, which can significantly impact their treatment journey. Consequently, Rozel 60 mg pfs is a vital resource for enhancing bone health in cancer patients.
Преимущества
Rozel 60 mg PFS has been shown to be effective in reducing the risk of fractures in patients with osteoporosis and increasing bone density and strength, resulting in a lower risk of fractures in the spine, hip, and other bones. Rozel 60 mg is effective in reducing the risk of fractures in patients with bone metastases (spread of cancer to the bones).
Побочные эффекты
Anti-resorptive Drug Rozel may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Наиболее распространенные побочные эффекты
• Arm or leg pain
• Joint pain
• Muscle or bone pain
• Constipation,
• Abdominal discomfort
• Hair loss
• Skin rash
• Tingling, pain, or numbness that moves down your leg
Распространенные побочные эффекты
• Upper respiratory tract infection
• Frequent or painful urination, blood in urine, inability to hold urine
• Musculoskeletal
• Severe leg or joint pain
Как использовать
Rozel 60 mg PFS can be administered to you subcutaneously (under the skin) by a doctor or nurse. You should also take calcium and vitamin D supplements while being on treatment with Anti-resorptive Drug Rozel. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Rozel 60 mg PFS. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Rozel 60 mg PFS should be used with caution in patients having severe kidney problems. Patients with severe kidney impairment (creatinine clearance < 30 mL/min) or receiving dialysis are at greater risk of developing hypocalcaemia. Consult your doctor before receiving Rozel 60 mg.
• Breastfeeding: It is not known whether Rozel 60 mg PFS passes into breast milk. If you are breastfeeding and taking Rozel 60 mg it is important to talk to your doctor about the potential risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Rozel 60 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Rozel 60 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Rozel 60 mg PFS may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Rozel 60 mg PFS may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Denosumab Injection 60 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Rozel 60 mg PFS has no or negligible influence on the ability to drive and use machines.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.